Merz Therapeutics

Vensica is a medical technology company focused on developing an innovative ultrasound-based drug delivery system for the treatment of urinary bladder conditions, particularly overactive bladder (OAB) and bladder cancer. The company's approach seeks to overcome the limitations of traditional drug administration methods, which involve catheter insertion and are often painful and ineffective. By utilizing ultrasound technology, Vensica's system allows for a needle-free, quick, and pain-free drug instillation procedure. The application of ultrasound enhances drug uptake and penetration into the bladder wall, aiming to improve treatment efficacy and reduce the high recurrence rates commonly associated with urinary bladder cancer. This method represents a significant advancement in therapeutic approaches, enabling healthcare providers to offer safer and more effective treatment options for patients.

Vensica is a medical technology company focused on developing an innovative ultrasound-based drug delivery system for the treatment of urinary bladder conditions, particularly overactive bladder (OAB) and bladder cancer. The company's approach seeks to overcome the limitations of traditional drug administration methods, which involve catheter insertion and are often painful and ineffective. By utilizing ultrasound technology, Vensica's system allows for a needle-free, quick, and pain-free drug instillation procedure. The application of ultrasound enhances drug uptake and penetration into the bladder wall, aiming to improve treatment efficacy and reduce the high recurrence rates commonly associated with urinary bladder cancer. This method represents a significant advancement in therapeutic approaches, enabling healthcare providers to offer safer and more effective treatment options for patients.